Nations U. United Nations. United Nations (2024) Population. Available from: https://www.un.org/en/global-issues/population. Accessed 15 Jun 2024

Home | Government of India [Internet] (2024). Available from: https://censusindia.gov.in/census.website/. Accessed 16 Jun 2024

UNFPA India [Internet] (2024) India ageing, elderly to make up 20% of population by 2050: UNFPA report. Available from: https://india.unfpa.org/en/news/india-ageing-elderly-make-20-population-2050-unfpa-report. Accessed 16 Jun 2024

Mithal A, Bansal B, Kyer CS, Ebeling P (2014) The asia-pacific regional audit-epidemiology, costs, and burden of osteoporosis in India 2013: a report of International osteoporosis foundation. Indian J Endocrinol Metab 18(4):449–454

Article  PubMed  PubMed Central  Google Scholar 

Khadilkar AV, Mandlik RM (2015) Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Womens Health 19(7):841–850

Article  Google Scholar 

Barik D, Thorat A (2015) Issues of unequal access to public health in India. Front Public Health 27(3):245

Google Scholar 

Bhadada SK, Chadha M, Sriram U, Pal R, Paul TV, Khadgawat R et al (2021) The Indian society for bone and mineral research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults. Arch Osteoporos 16(1):102

Article  PubMed  Google Scholar 

Nagendra L, Bhavani N, Menon VU, Pavithran PV, Menon AS, Abraham N et al (2021Apr 14) FRAX-based osteoporosis treatment guidelines for resource-poor settings in India. Arch Osteoporos 16(1):69

Article  PubMed  Google Scholar 

Tosteson ANA, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 19(4):437–447

Article  CAS  Google Scholar 

Pharmaceuticals & Medical Devices Bureau of India [Internet] (2024) Available from: https://janaushadhi.gov.in/ProductList.aspx. Accessed 16 Jun 2024

Hiligsmann M, Ethgen O, Bruyère O, Richy F, Gathon HJ, Reginster JY (2009) Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health J Int Soc Pharmacoeconomics Outcomes Res 12(5):687–696

Article  Google Scholar 

Sharma D, Prinja S, Aggarwal AK, Rajsekar K, Bahuguna P (2023) Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment. Lancet Reg Health Southeast Asia 16:100241

Article  PubMed  PubMed Central  Google Scholar 

Hiligsmann M, Reginster JY, Tosteson ANA, Bukata SV, Saag KG, Gold DT et al (2019) Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) and the US branch of the international osteoporosis foundation. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 30(1):45–57

Article  CAS  Google Scholar 

Yong EL, Ganesan G, Kramer MS, Logan S, Lau TC, Cauley JA et al (2019) Hip fractures in Singapore: ethnic differences and temporal trends in the new millennium. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 30(4):879–886

Article  CAS  Google Scholar 

Chandran M, Lau TC, Gagnon-Arpin I, Dobrescu A, Li W, Leung MYM et al (2019) The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options. Arch Osteoporos 14(1):114

Article  PubMed  Google Scholar 

Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res Off J Am Soc Bone Miner Res 15(4):721–739

Article  CAS  Google Scholar 

Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 15(3):175–179

Article  CAS  Google Scholar 

Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35(2):375–382

Article  CAS  PubMed  Google Scholar 

India - Sample Registration System (SRS)-Statistical Report 2018 [Internet] (2024) Available from: https://censusindia.gov.in/nada/index.php/catalog/44374. Accessed 12 Jun 2024

Hiligsmann M, Williams SA, Fitzpatrick LA, Silverman SS, Weiss R, Reginster JY (2019) Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture. Semin Arthritis Rheum 49(2):184–96

Article  CAS  PubMed  Google Scholar 

Parker MJ, Anand JK (1991) What is the true mortality of hip fractures? Public Health 105(6):443–446

Article  CAS  PubMed  Google Scholar 

Department of Community Medicine & School of Public Health PGIMER Chandigarh [Internet] (2024) Available from: https://www.healtheconomics.pgisph.in/costing_web/. Accessed 12 Jun 2024

Reserve Bank of India - Reference Rate Archive [Internet] (2024) Available from: https://www.rbi.org.in/scripts/ReferenceRateArchive.aspx. Accessed 11 Sept 2024

Jyani G, Prinja S, Garg B, Kaur M, Grover S, Sharma A et al (2023) Health-related quality of life among Indian population: the EQ-5D population norms for India. J Glob Health 17(13):04018

Article  Google Scholar 

Borgström F, Lekander I, Ivergård M, Ström O, Svedbom A, Alekna V et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)–quality of life during the first 4 months after fracture. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 24(3):811–823

Article  Google Scholar 

Hiligsmann M, Ethgen O, Richy F, Reginster JY (2008) Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int 82(4):288–292

Article  CAS  PubMed  Google Scholar 

Overview | Bisphosphonates for treating osteoporosis | Guidance | NICE [Internet]. NICE (2017) Available from: https://www.nice.org.uk/guidance/ta464. Accessed 12 Jun 2024

Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY et al (2015) A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. Pharmacoeconomics 33(3):205–224

Article  PubMed  Google Scholar 

Ström O, Landfeldt E, Garellick G (2015) Residual effect after oral bisphosphonate treatment and healthy adherer effects–the Swedish Adherence Register Analysis (SARA). Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 26(1):315–325

Article  Google Scholar 

Iuga AO, McGuire MJ (2014) Adherence and health care costs. Risk Manag Healthc Policy 20(7):35–44

Google Scholar 

Hiligsmann M, McGowan B, Bennett K, Barry M, Reginster JY (2012) The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland. Value Health J Int Soc Pharmacoeconomics Outcomes Res 15(5):604–612

Article  Google Scholar 

Fatoye F, Smith P, Gebrye T, Yeowell G (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4):e027049

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallagher AM, Rietbrock S, Olson M, van Staa TP (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res Off J Am Soc Bone Miner Res 23(10):1569–1575

Article  Google Scholar 

Liew D, Chapurlat RD, Sornay-Rendu E, Lespessailles E, Peng Y, Seeman E (2021) Cost-effectiveness of treatment of women aged 70 years and older with both osteopenia and microstructural deterioration. Bone 142:115682

Article  CAS  PubMed  Google Scholar 

Rajan R, Paul J, Cherian KE, Asha HS, Kapoor N, Paul TV (2020) FRAX® with or without BMD and TBS predicts fragility fractures in community-dwelling rural southern Indian postmenopausal women. Arch Osteoporos 15(1):82

Article  PubMed  Google Scholar 

Bansal B, Mithal A, Chopra SR, Bhanot S, Kuchay MS, Farooqui KJ (2018) Judicious use of DXA-BMD in assessing fracture risk by using clinical risk factors in the Indian population. Arch Osteoporos 13(1):115

Article  PubMed  Google Scholar 

Chandran M, Ganesan G, Tan KB, Reginster JY, Hiligsmann M (2021) Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 32(1):133–144

Article  CAS  Google Scholar 

Chandran M, Ganesan G, Tan KB, Reginster JY, Hiligsmann M (2021) Using health-economic evidence to support policy-level decision-making in Singapore-sensitivity analysis that provides further confidence in fracture probability-based cost-effective intervention thresholds. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 32(4):787–789

Article  CAS  Google Scholar 

Lippuner K, Johansson H, Borgström F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 23(11):2579–2589

Article  CAS  Google Scholar 

Garg S, Tripathi N, Ranjan A, Bebarta KK (2021) Comparing the average cost of outpatient care of public and for-profit private providers in India. BMC Health Serv Res 21(1):838

Article  PubMed